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42 Comparison of 2 nasal potential difference measurement (NPD)
methods (needle–abrasia): Is one more patient-friendly than the
other?
E. De Wachter1, I. De Schutter1, P. Haentjens1, S. Stinckens1, A. Malfroot1. 1UZ
Brussel, CF Clinic, Brussels, Belgium
NPD is a valuable diagnostic tool in case of questionable CF. Currently, 2 methods,
that are considered equivalent, are used: (A) the Calomel/agar method using a
needle as subcutaneous reference electrode (RE) and (B) the AgCl/ECG cream
method using AgCl electrodes and ECG cream on abraded skin as RE. NPD is
measured with a Marquat® catheter under the inferior turbinate (IT).
Aim: To compare the subjects’ acceptance for the 2 methods.
Methods: CF patients and healthy volunteers (HV) had method A and B in 2
nostrils on separate days. After each test they completed the questionnaire (Q):
Did you experience pain at the RE site, at the IT site, during perfusion? Was the
procedure annoying? Would you be prepared to repeat NPD? Which method do
you prefer?
Results: 50 Qs were completed by 12 CF patients (mean age 26.6 y) and 14 HV
(mean age 24.7 y). 16/50 (10A/6B, 3CF/13HV) reported pain at RE site, 7/50
(4A/3B, 3CF/4HV) at IT site, and 1/50 (A, HV) during nasal perfusion. 12/50
(9A/3B, 8CF/4HV) found the procedure annoying. 37/50 would agree to repeat
NPD, 13/50 probably would. 9/24 subjects (3CF/6HV) preferred method A, 5/24
(2CF/3HV) method B and 10/24 (5CF/5HV) had no preference. 2nd testing (B)
was refused twice (2CF) for reasons not related to the test. CF patients reported
less pain at RE site compared to HV (p = 0.017). No other statistical difference was
found between both tests or between subject groups.
Discussion: Overall, NPD was well tolerated. CF patients reported less pain at RE
site compared to HV. Both methods were equally accepted by the study subjects.
Further analyses of the quality of the tracings is needed to decide which method is
most accurate.
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Objectives: CF is the most common lethal hereditary disease in the caucasian
population. Currently, no sensitive, radiation-free methods are available to localize
and quantify lung inﬂammation. PET-TC has been proposed for the localization
and quantiﬁcation of active inﬂammation in CF lung, but its use is limited by high
exposure to ionizing radiation and high costs. Developments in MRI have made
possible the clinical application of lung-MRI to obtain not only morphological but
also functional information. Our propose is giving an overview of these new MR
tecniques and their potential application in CF population.
Methods: In this study will be enrolled, during 12 months, 30 patients (age >8),
15 cases and 15 controls. Each patients will be undergo to two RM examinations:
pre and post antibiotic for the case group; before and after 2 weeks for the
control group. The MR examination were performed on a 1.5 T MR scanner
(Avanto Siemens) with different sequences: TRUFI with spirometer, Propeller,
DWI, Fourier decomposition. In post-processing were calculated and showed the
diffusion and perfusion maps with ICE program (Siemens) and the DWI features
with Matlab2010.
Conclusion: Our preliminary results show the DWI seems to be sensitive to lung
inﬂammation and with the morphological sequences we can see the bronchiectasis,
mucous plugging, consolidation and air tapping without undergoing the patient to
ionizing radiation. Lung-MRI has the potential to supply new relevant functional
information in thoracic imaging. Its impact in CF follow-up has still to be deﬁned,
but it might open new therapeutic scenarios in CF and in other lung disease.
44 Nitrogen washout using an ultrasonic device for routine
measurement of the LCI in patients with CF
S. Fuchs1, E. Petri2, P. Ku¨ster2, G. Hu¨lskamp2, M. Gappa1. 1Marien Hospital
Wesel, Department of Paediatrics, Wesel, Germany; 2Clemenshospital Mu¨nster,
Department of Paediatrics, Mu¨nster, Germany
Objectives: Inert gas multiple breath washout (MBW) for calculating the Lung
Clearance Index (LCI) has become popular for assessing ventilation inhomogeneity
(VI) as an early indicator of Cystic Fibrosis (CF) lung disease. However, routine
use has been difﬁcult as inert tracer gases certiﬁed for medical purposes are
not universally available. Using nitrogen washout (MBWN2) with 100% oxygen
overcomes this problem but has rarely been used in patients with CF since
commercial equipment is available.
The aim of this study was to assess whether LCIN2 discriminates between patients
and controls and detects CF lung disease more often than spirometry.
Methods: 37 patients with CF (3.9–40.8 years) and 40 controls (6.9–84.4 years)
performed 2−3 single MBWN2 using the EasyOne Pro LAB™ (ndd Switzerland).
30/37 patients performed a comparative spirometry.
Mean (SD) LCIN2 was 9.2 (2.50) in patients and 6.5 (0.72) in controls. Mean
difference between the groups (95%CI, p-value) was −2.627 (−3.496; −1.768,
<0.001). Mean FEV1% predicted (SD) in patients was 82% (26.8). In 15/30 LCIN2
and FEV1 were abnormal, in 3/30 LCIN2 and FEV1 were normal and in 12/30
LCIN2 was abnormal while FEV1 remained normal.
Conclusion: LCIN2 discriminated signiﬁcantly between patients and controls. 80%
of the patients with a normal FEV1 had abnormal LCIs indicating manifestation of
CF lung disease within the lung periphery that was not detectable using spirometry
alone. Results were comparable to published data obtained with different equipment
and with using inert tracer gases.
We conclude that MBWN2 reﬂects VI similar to inert gas MBW and can thus be
used for routine monitoring of patients with CF.
45 Exhaled nitric oxide is associated with Pseudomonas aeruginosa
infection and peripheral airway obstruction in cystic ﬁbrosis
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Objectives: Exhaled nitric oxide (FeNO) is decreased in obstructive patients, but
NO also reduces the epithelial adhesion and uptake of P. aeruginosa. Thus, the
lower levels of NO will potentiate Pseudomonas colonization of patients with CF.
The aim of this study was to investigate whether airway NO level are associated
with Pseudomonas aeruginosa infection and peripheral airway obstruction in cystic
ﬁbrosis.
Methods: Exhaled NO was determined with a chemiluminescence analyzer (Niox
Mino, Aerocrine, Solna, Sweden). Single breath FENO measurements at 50mL/sec
were performed in 18 stable CF patients (age (mean±SD), 14.7±6.6 years) and 15
non-smoking controls (age 17.2±7.0 years). All subjects underwent comprehensive
pulmonary function assessment (MasterScreen Diffusion, E. Jaeger, Germany).
CF patients revealed signiﬁcantly lower FEV1 compared to controls (81.6±18.5 vs.
105.9±11.0 L; p< 0.001) but FeNO values did not differ between the two groups
(14.1±6.9 vs 13.0±4.6 ppb; p = 0.619). Patient population was further divided
whether there was (PI+; n = 10) or not (PI−; n = 8) Pseudomonas infection. In
the PI (+) FeNO was signiﬁcantly lower compared to PI (−) group (8.0±3.3 vs
20.2±2.7 ppb; p< 0.001). The PI (+) patients also had lower spirometric indices −
MEF50% = 54.7±27.9 vs 82.7±13.2 %pred; p = 0.032 and MEF25% = 33.6±9.6 vs
57.7±13.5% %pred; p< 0.001.
Conclusion: Patients with CF who are PI (+) have lower levels of exhaled NO.
They also reveal signiﬁcant peripheral airway obstruction compared to PI (−). No
difference was found in FeNO between CF patients and controls.
